The Impact of Multimorbidity on Healthcare Utilization and Expenditure: Evidence from China

Ding Liman

Asian Journal of Social Pharmacy ›› 2024, Vol. 19 ›› Issue (4) : 401 -408.

Asian Journal of Social Pharmacy ›› 2024, Vol. 19 ›› Issue (4) :401 -408.
research-article
The Impact of Multimorbidity on Healthcare Utilization and Expenditure: Evidence from China
Author information +
History +

Abstract

Objective To investigate the impact of multimorbidity on China’s healthcare utilization and expenditure. Methods A two-part model was used to analyze the outpatient cares based on the data from CHARLS 2015 wave. Results and Conclusion As the prevalence of multimorbidity was 36.6% among 15 523 middle-aged and elderly respondents in China, the multimorbidity increased the likelihood of outpatient service, while the total outpatient expenditure did not increase significantly as well as the OOP expenditure. Secondly, although there was a similar probability of outpatient visit, the patients with multimorbidity excluding diabetes and (or) hypertension, had not been concerned by China’s Chronic Condition Management Programs (CCCMP) yet. Thirdly, the patients with multimorbidity increased the outpatient visits to different types of hospitals. Under CCCMP intervention, the patients did not switch from the county/city hospital to primary healthcare centers and township hospital. A costeffective strategy for providing services to patients with multimorbid conditions is needed, the focus of CCCMP should be switched from the single chronic disease to the multimorbidity.

Keywords

multimorbidity / healthcare utilization and expenditure / two-part model / China

Cite this article

Download citation ▾
Ding Liman. The Impact of Multimorbidity on Healthcare Utilization and Expenditure: Evidence from China. Asian Journal of Social Pharmacy, 2024, 19(4): 401-408 DOI:

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Beard JR, Bloom DE. Towards a comprehensive public health response to population ageing[J]. The Lancet, 2015, 385 (9968): 658-661.

[2]

Marengoni A, Angleman S, Melis RJ, et al. Aging with multimorbidity: A systematic review of the literature[J]. Ageing Research Reviews, 2011, 10 (4): 430-439.

[3]

Palladino R, Pennino F, Finbarr M, et al. Multimorbidity and health outcomes in older adults in ten European health systems, 2006-2015 [J]. Health Affairs, 2019, 38 (4): 613-623.

[4]

Fortin M, Stewart M, Poitras M, et al. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology[J]. Annals of Family Medicine, 2012, 10 (2): 142-151.

[5]

Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study[J]. The Lancet, 2012, 380 (9836): 37-43.

[6]

Rijken M, Struckmann V, Heide I, et al. How to Improve Care for People with Multimorbidity in Europe?Copenhagen: European Observatory on Health Systems and Policies[M]. Denmark: World Health Organization Regional Office for European, 2017: 29144712.

[7]

Nunes BP, Thume E, Facchini LA. Multimorbidity in older adults: Magnitude and challenges for the Brazilian health system[J]. BMC Public Health, 2015, 15 (1): 1172.

[8]

Catalalopez F, Alonsoarroyo A, Page MJ, et al. Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis[J]. Plos One, 2018, 13 (1): e0189091

[9]

Bahler C, Huber CA, Brungger B, et al. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: A claims data based observational study[J]. BMC Health Services Research, 2015, 15 (1): 23.

[10]

Feng Zhanlian, Liu Chang, Guan Xinping, et al. China’s rapidly aging population creates policy challenges in shaping a viable long-term care system[J]. Health Affairs, 2012, 31 (12): 2764-2773.

[11]

Ding Liman, Wu Jing. The impact of China’s national essential medicine policy and its implications for urban outpatients: A multivariate difference-in-differences study[J]. Value in Health, 2017, 20 (3): 412-419.

[12]

Palladino R, Lee JT, Ashworth M, et al. Associations between multimorbidity, healthcare utilization and health status: Evidence from 16 European countries[J]. Age and Ageing, 2016, 45 (3): 431-435.

[13]

Skinner HG, Coffey RM, Jones JM, et al. The effects of multiple chronic conditions on hospitalization costs and utilization for ambulatory care sensitive conditions in the United States: A nationally representative cross-sectional study[J]. BMC Health Services Research, 2016, 16 (1): 77.

[14]

Chen He, Cheng Mengling, Zhuang Yu, et al. Multimorbidity among middle‐aged and older persons in urban China: Prevalence, characteristics and health service utilization[J]. Geriatrics & Gerontology International, 2018, 18 (10): 1447-1452.

[15]

Lee JT, Hamid F, Pati S, et al. Impact of non-communicable disease multimorbidity on healthcare utilization and out-of-pocket expenditures in middle- income countries: Cross sectional analysis[J]. Plos One, 2015, 10 (7): e0127199

[16]

Harry HX., Wang Jiaji, Wong SY, et al. Effect of employment and social medical insurance on hospital admissions for people living with multimorbidity in China: Analysis of a large community household survey[J]. The Lancet, 2015, 386: S19.

[17]

Hou Zhiyuan, Meng Qingyue, Zhang Yuting. Hypertension prevalence, awareness, treatment, and control following China’s healthcare reform[J]. American Journal of Hypertension, 2016, 29 (4): 428-431.

[18]

Zhao Yaohui, Hu Yisong, Smith JP, et al. Cohort profile: The China health and retirement longitudinal study (CHARLS)[J]. International Journal of Epidemiology, 2014, 43 (1): 61-68.

[19]

Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter[J]. Journal of Health and Social Behavior, 1995, 36 (1): 1-10.

[20]

Tian Fan, Meng Steven Siyao, Qiu Peiyuan. Childhood adversities and mid-late depressive symptoms over the life course: Evidence from the China health and retirement longitudinal study[J]. Journal of Affective Disorders, 2019, 245: 668-678.

[21]

Luo Yanan, Wang Zhenjie, Zheng Xiaoying. Association between the change of daily living activities and symptoms of depression in Chinese middle-aged and elderly people[J]. Chinese Journal of Epidemiology, 2017, 38 (8): 1055-1059. (in Chinese)

[22]

Li LW, Liu JY, Xu HM, et al. Understanding rural-urban differences in depressive symptoms among older adults in China[J]. Journal of Aging and Health, 2016, 28 (2): 341-362.

[23]

Bogan VL, Fertig AR. Portfolio choice and mental health[J]. Review of Finance, 2013, 17 (3): 955-992.

[24]

Turvey C, Wallace RB, Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly[J]. International Psychogeriatrics, 1999, 11 (2): 139-148.

[25]

Zhang AW, Nikoloski Z, Mossialos E. Does health insurance reduce out-of-pocket expenditure?Heterogeneity among China’s middle-aged and elderly[J]. Social Science & Medicine, 2017, 190: 11-19.

[26]

Li Xin, Zhang Wei. The impacts of health insurance on health care utilization among the older people in China[J]. Social Science & Medicine, 2013, 85: 59-65.

[27]

Ying Liang, Yang Hui. Australian chronic disease management plan and its enlightenment to China[J]. Chinese General Practice, 2019, 22 (34): 4184-4189.

18

Accesses

0

Citation

Detail

Sections
Recommended

/